Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. R. Lackner

Molecular Predictors of Response to a Humanized Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody in Breast and Colorectal Cancer

Molecular Cancer Therapeutics

Cancer Research

Oncology

2009

English

Related publications

Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-Like Growth Factor I Receptor Monoclonal Antibody

Molecular Cancer Therapeutics

Cancer Research

Oncology

2011

English

Apoptosis Induced by an Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in a Human Colorectal Carcinoma Cell Line and Its Delay by Insulin.

Journal of Clinical Investigation

Medicine

1995

English

Phase 1 Pharmacokinetic Study of MK-0646 (Dalotuzumab), an Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody, in Combination With Cetuximab and Irinotecan in Japanese Patients With Advanced Colorectal Cancer

Cancer Chemotherapy and Pharmacology

English

Insulin-Like Growth Factor Receptor Type I as a Target for Cancer Therapy

Frontiers in Bioscience - Scholar

English

A Phase I Study of Farletuzumab, a Humanized Anti-Folate Receptor Α Monoclonal Antibody, in Patients With Solid Tumors

Investigational New Drugs

Oncology

Pharmacology

2014

English

Correlation of Insulin-Like Growth Factor 1 Receptor Expression With Different Molecular Subtypes of Breast Cancer in the UAE

English

Differential Roles of the Insulin and Insulin-Like Growth Factor-I (IGF-I) Receptors in Response to Insulin and IGF-I.

Journal of Biological Chemistry

English

Insulin-Like Growth Factor-I and Prostate Cancer: A Meta-Analysis

British Journal of Cancer

Cancer Research

Oncology

2001

English

Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. R. Lackner

Molecular Predictors of Response to a Humanized Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody in Breast and Colorectal Cancer

Related publications

Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-Like Growth Factor I Receptor Monoclonal Antibody

Apoptosis Induced by an Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in a Human Colorectal Carcinoma Cell Line and Its Delay by Insulin.

Phase 1 Pharmacokinetic Study of MK-0646 (Dalotuzumab), an Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody, in Combination With Cetuximab and Irinotecan in Japanese Patients With Advanced Colorectal Cancer

Insulin-Like Growth Factor Receptor Type I as a Target for Cancer Therapy

A Phase I Study of Farletuzumab, a Humanized Anti-Folate Receptor Α Monoclonal Antibody, in Patients With Solid Tumors

Correlation of Insulin-Like Growth Factor 1 Receptor Expression With Different Molecular Subtypes of Breast Cancer in the UAE

Differential Roles of the Insulin and Insulin-Like Growth Factor-I (IGF-I) Receptors in Response to Insulin and IGF-I.

Insulin-Like Growth Factor-I and Prostate Cancer: A Meta-Analysis

Phase I Study of the Anti Insulin-Like Growth Factor 1 Receptor (IGF-1R) Monoclonal Antibody, AVE1642, as Single Agent and in Combination With Bortezomib in Patients With Relapsed Multiple Myeloma